Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara

BACKGROUND: The safety and immunogenicity of PfAMA1, adjuvanted with Alhydrogel(®) was assessed in malaria–experienced Malian adults. The malaria vaccine, PfAMA1-FVO [25-545] is a recombinant protein Pichia pastoris-expressed AMA-1 from Plasmodium falciparum FVO clone adsorbed to Alhydrogel(®), the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Malar J
Egile Nagusiak: Thera, Mahamadou A., Coulibaly, Drissa, Kone, Abdoulaye K., Guindo, Ando B., Traore, Karim, Sall, Abdourhamane H., Diarra, Issa, Daou, Modibo, Traore, Idrissa M., Tolo, Youssouf, Sissoko, Mady, Niangaly, Amadou, Arama, Charles, Baby, Mounirou, Kouriba, Bourema, Sissoko, Mahamadou S., Sagara, Issaka, Toure, Ousmane B., Dolo, Amagana, Diallo, Dapa A., Remarque, Edmond, Chilengi, Roma, Noor, Ramadhani, Sesay, Sanie, Thomas, Alan, Kocken, Clemens H., Faber, Bart W., Imoukhuede, Egeruan Babatunde, Leroy, Odile, Doumbo, Ogobara K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006270/
https://ncbi.nlm.nih.gov/pubmed/27577237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-016-1466-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak